Detalhe da pesquisa
1.
Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety.
Thorax
; 78(11): 1097-1104, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37028940
2.
Informal caregivers experience of supplemental oxygen in pulmonary fibrosis.
Health Qual Life Outcomes
; 15(1): 133, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28668090
3.
Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis.
BMC Pulm Med
; 17(1): 152, 2017 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29166901
4.
Seeking and sharing: why the pulmonary fibrosis community engages the web 2.0 environment.
BMC Pulm Med
; 16: 4, 2016 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26754048
5.
Development of ATAQ-LAM: a tool to assess quality of life in Lymphangioleiomyomatosis.
Health Qual Life Outcomes
; 13: 112, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26220448
6.
"Getting stuck with LAM": patients perspectives on living with lymphangioleiomyomatosis.
Health Qual Life Outcomes
; 12: 79, 2014 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885591
7.
Protocol for a mixed-methods study of supplemental oxygen in pulmonary fibrosis.
BMC Pulm Med
; 14: 169, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361630
8.
Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis.
ERJ Open Res
; 7(2)2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34109243
9.
Looking ahead and behind at supplemental oxygen: A qualitative study of patients with pulmonary fibrosis.
Heart Lung
; 46(5): 387-393, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28774655